Krystal Biotech Files 8-K on Shareholder Votes
Ticker: KRYS · Form: 8-K · Filed: May 19, 2025 · CIK: 1711279
| Field | Detail |
|---|---|
| Company | Krystal Biotech, Inc. (KRYS) |
| Form Type | 8-K |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Krystal Biotech is holding a shareholder vote, details to follow.
AI Summary
Krystal Biotech, Inc. filed an 8-K on May 19, 2025, to report on matters submitted to a vote of its security holders. The filing indicates a submission of matters for shareholder approval, though specific details of the vote or the matters themselves are not elaborated upon in this excerpt.
Why It Matters
This filing signals that Krystal Biotech is engaging its shareholders on important corporate decisions, which could impact the company's direction and shareholder value.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial information or significant operational changes.
Key Players & Entities
- Krystal Biotech, Inc. (company) — Registrant
- May 19, 2025 (date) — Date of earliest event reported
- 2100 Wharton Street, Suite 701 Pittsburgh, Pennsylvania 15203 (address) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Krystal Biotech's security holders?
The provided excerpt does not specify the exact matters submitted for a vote, only that such matters were presented.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 19, 2025.
What is Krystal Biotech's principal executive office address?
The principal executive offices are located at 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203.
Under which section of the Securities Exchange Act of 1934 is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Krystal Biotech's SIC code?
Krystal Biotech's Standard Industrial Classification (SIC) code is 2836 for Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 19, 2025 regarding Krystal Biotech, Inc. (KRYS).